Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 4/20 | 0.36 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.35 |
| ▸ | TUBB | P07437 | 1/20 | 0.35 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.35 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.35 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.35 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.35 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.35 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.35 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.35 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.35 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.35 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15688424 | 1.00 | KDM4E (0.46) | KDM4EFDPSCYP3A4TDP1TSHR | |
| SCHEMBL5147276 | 0.82 | KDM4E (0.50) | KDM4EFDPSCYP3A4TDP1ALDH1A1 | |
| SCHEMBL5161207 | 0.82 | KDM4E (0.50) | KDM4EFDPSCYP3A4TDP1ALDH1A1 | |
| SCHEMBL28304173 | 0.82 | CYP3A4 (0.54) | CYP3A4TDP1TSHRALDH1A1APP | |
| SCHEMBL18854461 | 0.79 | KDM4E (0.47) | KDM4EFDPSCYP3A4TSHRALDH1A1 | |
| SCHEMBL18854463 | 0.79 | KDM4E (0.47) | KDM4EFDPSCYP3A4TSHRALDH1A1 | |
| SCHEMBL377116 | 0.79 | KDM4E (0.41) | KDM4EFDPSCYP3A4TDP1TSHR | |
| SCHEMBL377117 | 0.79 | KDM4E (0.41) | KDM4EFDPSCYP3A4TDP1TSHR | |
| SCHEMBL11681140 | 0.78 | TSHR (0.42) | KDM4EFDPSCYP3A4TDP1TSHR | |
| SCHEMBL11681141 | 0.78 | TSHR (0.42) | KDM4EFDPSCYP3A4TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180016281-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | JANSSEN SCIENCES IRELAND UC (IE) | 2018-01-18 | — | — | US | disclosed |
| US-20180016281-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | JANSSEN SCIENCES IRELAND UC (IE) | 2018-01-18 | — | — | US | disclosed |
| US-20180009819-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | JANSSEN SCIENCES IRELAND UC (IE) | 2018-01-11 | — | — | US | disclosed |
| US-9802943-B2 | HIV inhibiting bicyclic pyrimidine derivatives | JANSSEN SCIENCES IRELAND UC (IE) | 2017-10-31 | — | — | US | disclosed |
| US-9802943-B2 | HIV inhibiting bicyclic pyrimidine derivatives | JANSSEN SCIENCES IRELAND UC (IE) | 2017-10-31 | — | — | US | disclosed |
| US-20160355519-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | JANSSEN SCIENCES IRELAND UC (IE) | 2016-12-08 | — | — | US | disclosed |
| US-20160355519-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | JANSSEN SCIENCES IRELAND UC (IE) | 2016-12-08 | — | — | US | disclosed |
| US-9487518-B2 | HIV inhibiting bicyclic pyrimidine derivatives | JANSSEN SCIENCES IRELAND UC (IE) | 2016-11-08 | — | — | US | disclosed |
| US-9487518-B2 | HIV inhibiting bicyclic pyrimidine derivatives | JANSSEN SCIENCES IRELAND UC (IE) | 2016-11-08 | — | — | US | disclosed |
| EP-1807430-B1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | JANSSEN R & D IRELAND (IE) | 2014-07-23 | — | — | EP | disclosed |
| WO-2014072419-A1 | NOVEL ANTI-HIV COMPOUNDS | UNIVERSITEIT ANTWERPEN (BE) | 2014-05-15 | — | — | WO | disclosed |
| US-20120190697-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | JANSSEN SCIENCES IRELAND UC (IE) | 2012-07-26 | — | — | US | disclosed |
| US-20120190697-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | JANSSEN SCIENCES IRELAND UC (IE) | 2012-07-26 | — | — | US | disclosed |
| US-8153640-B2 | Reverse transcriptase inhibitors; use against HIV with drug resistance to NNRTI's (Non Nucleoside Reverse Transcriptase Inhibitor drugs); Diaryl Pyrrolo(2,3-d)pyrimidines, diaryl purines, diaryl v-triazolo(4,5-d)pyrimidines | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2012-04-10 | — | — | US | disclosed |
| US-8153640-B2 | Reverse transcriptase inhibitors; use against HIV with drug resistance to NNRTI's (Non Nucleoside Reverse Transcriptase Inhibitor drugs); Diaryl Pyrrolo(2,3-d)pyrimidines, diaryl purines, diaryl v-triazolo(4,5-d)pyrimidines | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2012-04-10 | — | — | US | disclosed |
| US-20080085907-A1 | Hiv Inhibiting Bicyclic Pyrimdine Derivatives | JANSSEN-CILAG (FR) | 2008-04-10 | — | — | US | disclosed |
| US-20080085907-A1 | Hiv Inhibiting Bicyclic Pyrimdine Derivatives | JANSSEN-CILAG (FR) | 2008-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009819-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | COX6C, ZC3HAV1L, RRM2B | KDM4E 3679/4885FDPS 2849/4885CYP3A4 328/4885 |
| US-20080085907-A1 | Hiv Inhibiting Bicyclic Pyrimdine Derivatives | CCR6, CD4, CCNT1 | KDM4E 3495/4885FDPS 2837/4885CYP3A4 207/4885 |
| US-20160355519-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | COX6C, ZC3HAV1L, RRM2B | KDM4E 3608/4885FDPS 2847/4885CYP3A4 336/4885 |
| US-20180016281-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | COX6C, ZC3HAV1L, CCR6 | KDM4E 3568/4885FDPS 2793/4885CYP3A4 375/4885 |
| US-20120190697-A1 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | ZC3HAV1, CCR6, COX6C | KDM4E 3725/4885FDPS 2886/4885CYP3A4 574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.